GSK Boosts Its Infectious Disease Portfolio With Brexafemme License

 
• By Joseph Haas
  
GSK HQ
GSK adds a novel antifungal to its infectious disease portfolio • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business